Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI).
Carberry J, Petrie MC, Lee MMY, Stanley B, Brooksbank KJM, Campbell RT, Good R, Jhund PS, Kellman P, Lang NN, Lindsay MM, Mangion K, Gardner RS, Mark PB, Meyer B, O'Donnell J, Orchard V, Shaukat A, Watkins S, McConnachie A, McMurray JJV, Welsh P, Sattar N, Berry C, Docherty KF.
Carberry J, et al. Among authors: meyer b.
Eur J Heart Fail. 2024 Dec 15. doi: 10.1002/ejhf.3560. Online ahead of print.
Eur J Heart Fail. 2024.
PMID: 39675781